Navigating the complex role of BAP1 in clear cell renal cell carcinoma

The BRCA1-associated protein 1 (BAP1) gene mutation defines a subtype of aggressive clear cell renal cell carcinoma (ccRCC) with distinct molecular phenotypes and poor prognosis. In-depth analysis of its regulatory role as a key tumor suppressor in multi-dimensional biological processes may help lay the groundwork for future precision treatment strategies, although their clinical implementation remains investigational. This review systematically summarizes the core functions of BAP1 in epigenetic regulation, DNA damage repair, remodeling of the immune microenvironment, and metabolic reprogramming. It also focuses on explaining the specific therapeutic vulnerabilities induced by BAP1 deficiency, including the synthetic lethal effect mediated by PARP inhibitors, the sensitivity of epigenetic targets such as EZH2/HDAC, and the synergistic mechanism of immune checkpoint inhibitors. The literature search was conducted based on the PubMed/Medline database, using keywords such as “BAP1”, “ccRCC”, “synthetic lethality”, “immunotherapy” for systematic screening and integrated analysis. BAP1-mutant ccRCC has become an important paradigm in precision oncology research. Currently, single-agent targeted or immunotherapy has shown initial efficacy, but the problem of drug resistance is prominent. Future therapeutic advances will depend on rationally designed combination regimens; whether biomarker-guided patient stratification can inform such regimens awaits prospective clinical validation.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-13
DOI
https://doi.org/10.1007/s12672-026-06290-5
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Navigating the complex role of BAP1 in clear cell renal cell carcinoma

Xiaoxiang Gong, Xia Wu, Likang Chen
1 links
Discover Oncology
Renal cell carcinoma treatment
article

Navigating the complex role of BAP1 in clear cell renal cell carcinoma

Xiaoxiang Gong, Xia Wu, Likang Chen
article en

Abstract

The BRCA1-associated protein 1 (BAP1) gene mutation defines a subtype of aggressive clear cell renal cell carcinoma (ccRCC) with distinct molecular phenotypes and poor prognosis. In-depth analysis of its regulatory role as a key tumor suppressor in multi-dimensional biological processes may help lay the groundwork for future precision treatment strategies, although their clinical implementation remains investigational. This review systematically summarizes the core functions of BAP1 in epigenetic regulation, DNA damage repair, remodeling of the immune microenvironment, and metabolic reprogramming. It also focuses on explaining the specific therapeutic vulnerabilities induced by BAP1 deficiency, including the synthetic lethal effect mediated by PARP inhibitors, the sensitivity of epigenetic targets such as EZH2/HDAC, and the synergistic mechanism of immune checkpoint inhibitors. The literature search was conducted based on the PubMed/Medline database, using keywords such as “BAP1”, “ccRCC”, “synthetic lethality”, “immunotherapy” for systematic screening and integrated analysis. BAP1-mutant ccRCC has become an important paradigm in precision oncology research. Currently, single-agent targeted or immunotherapy has shown initial efficacy, but the problem of drug resistance is prominent. Future therapeutic advances will depend on rationally designed combination regimens; whether biomarker-guided patient stratification can inform such regimens awaits prospective clinical validation.

Discover Oncology
Central South University (CN), Second Xiangya Hospital of Central South University (CN)
Good health and well-being
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon